SK Biopharmaceuticals Co., Ltd. (“SK Biopharmaceuticals”), as issuer, and SK Holdings Co., Ltd. (“SK Holdings”), as selling shareholder, on the deal. SK Biopharmaceuticals completed its initial…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
